Get in touchInvestors
The material works. The question is scale.
Spider silk sits at the intersection of three of the most significant market trends of the next decade — regenerative medicine, sustainable luxury, and advanced biomaterials.
The Opportunity
Early enough to be transformative
The addressable markets for medical scaffolding and luxury textiles are each multi-billion-dollar segments. DSH is early enough to be transformative, yet late enough to have demonstrated proof-of-concept on both tracks — a rare window where the science is de-risked but the value is not yet priced in.
3
Converging megatrends
2
Revenue tracks
1
Proprietary fibre source
What We're Building Toward
An honest roadmap
Near-term
- Research programmes reaching pre-clinical milestones
- Fashion line soft-launch around the couture unveiling
- Farm capacity scaling for research-grade fibre
Mid-term
- Regulatory submissions for the lead medical device
- First commercial fashion collection
- Initial fibre supply agreements
Long-term
- Scaled medical-device production
- Expanded luxury distribution
- Fibre supply partnerships across industries
The JV Structure
How the investment vehicle works
Capital is raised into the joint-venture holding and deployed across the medical and fashion tracks, with the supply entity feeding both. For investors with international portfolios, jurisdiction matters — so we set it out plainly.
The joint-venture vehicle
Centred in Dubai; the entity that raises and deploys capital.
Spider & Silk Supply — Taiwan
The research and production entity; the source of the fibre.
Medtech subsidiary — Australia
Carries device development and the regulatory pathway for medical applications.
Why Now
Actual spiders. Actual silk. No technology risk.
Synthetic spider-silk startups have burned hundreds of millions trying to brew the material in fermenters. Our approach sidesteps that risk entirely: the material already works. The question isn't whether — it's whether you can produce it at scale and deploy it commercially. That is exactly where DSH is focused.
Deck & Data Room
Request access
The pitch deck and supporting financials are available on request. We gate access — we like to know who's looking.
Partner & Advisory Inquiries
Beyond capital
For strategic partners — institutions, fashion houses, medical-device companies, and research universities — that want to engage with DSH at the operational level.
Start a conversation